147 related articles for article (PubMed ID: 25464014)
1. Casein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S).
Kim S; Jin B; Choi SH; Han KH; Ahn SH
PLoS One; 2014; 9(12):e113938. PubMed ID: 25464014
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III.
Kim S; Welsch C; Yi M; Lemon SM
J Virol; 2011 Jul; 85(13):6645-56. PubMed ID: 21525356
[TBL] [Abstract][Full Text] [Related]
3. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
Scheel TK; Prentoe J; Carlsen TH; Mikkelsen LS; Gottwein JM; Bukh J
PLoS Pathog; 2012; 8(5):e1002696. PubMed ID: 22654662
[TBL] [Abstract][Full Text] [Related]
4. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.
Yi M; Ma Y; Yates J; Lemon SM
J Virol; 2007 Jan; 81(2):629-38. PubMed ID: 17079282
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors.
McGivern DR; Masaki T; Williford S; Ingravallo P; Feng Z; Lahser F; Asante-Appiah E; Neddermann P; De Francesco R; Howe AY; Lemon SM
Gastroenterology; 2014 Aug; 147(2):453-62.e7. PubMed ID: 24768676
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.
Tellinghuisen TL; Foss KL; Treadaway J
PLoS Pathog; 2008 Mar; 4(3):e1000032. PubMed ID: 18369478
[TBL] [Abstract][Full Text] [Related]
7. Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.
Yi M; Ma Y; Yates J; Lemon SM
PLoS Pathog; 2009 May; 5(5):e1000403. PubMed ID: 19412343
[TBL] [Abstract][Full Text] [Related]
8. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
Wang Q; Li Y; Liu SA; Xie W; Cheng J
World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
Li Y; Yamane D; Lemon SM
J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.
Ramirez S; Li YP; Jensen SB; Pedersen J; Gottwein JM; Bukh J
Hepatology; 2014 Feb; 59(2):395-407. PubMed ID: 23913364
[TBL] [Abstract][Full Text] [Related]
11. Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.
Imhof I; Simmonds P
J Virol; 2010 May; 84(9):4597-610. PubMed ID: 20164226
[TBL] [Abstract][Full Text] [Related]
12. Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus.
Shimakami T; Welsch C; Yamane D; McGivern DR; Yi M; Zeuzem S; Lemon SM
Gastroenterology; 2011 Feb; 140(2):667-75. PubMed ID: 21056040
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
[TBL] [Abstract][Full Text] [Related]
14. NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains.
Benzine T; Brandt R; Lovell WC; Yamane D; Neddermann P; De Francesco R; Lemon SM; Perelson AS; Ke R; McGivern DR
PLoS Pathog; 2017 Jun; 13(6):e1006343. PubMed ID: 28594932
[TBL] [Abstract][Full Text] [Related]
15. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.
Mateu G; Donis RO; Wakita T; Bukh J; Grakoui A
Virology; 2008 Jul; 376(2):397-407. PubMed ID: 18455749
[TBL] [Abstract][Full Text] [Related]
16. Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee.
Yi M; Hu F; Joyce M; Saxena V; Welsch C; Chavez D; Guerra B; Yamane D; Veselenak R; Pyles R; Walker CM; Tyrrell L; Bourne N; Lanford RE; Lemon SM
J Virol; 2014 Apr; 88(7):3678-94. PubMed ID: 24429362
[TBL] [Abstract][Full Text] [Related]
17. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.
Li YP; Ramirez S; Gottwein JM; Scheel TK; Mikkelsen L; Purcell RH; Bukh J
Proc Natl Acad Sci U S A; 2012 May; 109(18):E1101-10. PubMed ID: 22467829
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
19. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
20. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
Liu S; Xiao L; Nelson C; Hagedorn CH
PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
